Lupus & antiphospholipid syndrome
A better self-efficacy is predictive of lower fatigue in systemic lupus erythematosus patients: Data from a Almenara Lupus Cohort
Authors' conclusion
A better self-efficacy is predictive of a subsequent lower fatigue, even after adjustment for possible confounders.
Study context
- Population
- SLE patients from a single-center prevalent cohort (Almenara Lupus Cohort)
- Participants
- 209 patients563 visits
- Outcome
- Fatigue (FACIT-F, higher score = lower fatigue) at the subsequent visit, predicted by self-efficacy (PROMIS) at the previous visit
- Follow-up
- Subsequent visit
Methodological detailssingle-centre, prevalent cohort, generalized estimating equations, multivariable models adjusted for possible confounders
- Single-centre
- Prevalent cohort
- Generalized estimating equations
- Multivariable models adjusted for possible confounders
Main finding
As reported in the abstract
Predictors of fatigue (FACIT-F) at subsequent visit, multivariable models
- Lower fatigue predicted by self-efficacy for managing symptoms and managing activities
- Adjusted for possible confounders
Observational data: associations, not effects.
Further findings
Baseline Functional Assessment of Chronic Illness Therapy - Fatigue (FACIT-F) and PROMIS self-efficacy scores
- FACIT-F
- 33.0 (10.2)
- Mean general self-efficacy
- 47.2 (10.4)
- Self-efficacy for managing emotions
- 44.6 (8.0)
- Self-efficacy for managing symptoms
- 47.7 (8.2)
- Self-efficacy for managing daily activities
- 45.5 (7.5)
- Self-efficacy for managing social interactions
- 42.9 (7.9)
- Self-efficacy for managing medications and treatment
- 43.9 (7.0)
- PROMIS score of 50 is the average for a clinical population; higher = greater self-efficacy
Original publication
A better self-efficacy is predictive of lower fatigue in systemic lupus erythematosus patients: Data from a Almenara Lupus Cohort. Lupus. Published 11 March 2025. doi:10.
Composed by AI from the published abstract and checked against it. How Briefs are made →